Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.

Abstract: A make-up emulsion composition includes an aqueous internal phase emulsified in an external fatty phase. The fatty phase includes at least one silicone oil, silicone resin, silica aerogel, spherical silica, clay, starch, pigment, and emulsifier. Methods of use are also provided.

Abstract: Methods of inducing CD8+ T cell infiltration into a tumor in a patient in need thereof comprising administering a radioimmunoconjugate that is capable of binding a target expressed by at least some cells in a tumor.

Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.

Abstract: A make-up emulsion composition includes an aqueous internal phase emulsified in an external fatty phase. The fatty phase includes at least one silicone oil, silicone resin, silica aerogel, spherical silica, clay, starch, pigment, and emulsifier. Methods of use are also provided.

Abstract: Gel compositions including water, a water-soluble or water-dispersible gelling agent comprising at least one copolymer formed from sulfonic acid acrylic monomer are provided. The compositions further include a film-forming polymer selected from a film-forming acrylic polymer, a film-forming urethane polymer, and combinations thereof. The compositions further include hydrophobic silica and are substantially free of fatty compounds.

Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.

Abstract: The present disclosure relates to anhydrous cosmetic composition comprising hydrophobic silica particles, PMMA particles, silicone oil, hydrocarbon oil, silicone elastomer and silicone emulsifier.

Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.

Abstract: Disclosed is a long wearing cosmetic product with elegant glide and feel with cooling sensation and impactful color intensity with high coverage. The disclosed combination of a silicone resin, an ethylenic polymer including a monomer having a bicyclic group, and a taurate copolymer provides a flexible/soft film on eye lids which is not brittle and wears longer for hours.

Abstract: Using a method of operating a system that includes remote servers, and at least one electronic device, a user verbally instructs the electronic device to activate a function. The system uses the remote servers and other parts of the system to determine that the function is not currently enabled and requires a user-acknowledgment to terms of use before the function is enabled. The system provides information on the terms of use and solicits a user-acknowledgment to the terms of use. The user provides a verbal acknowledgment of the terms of use and the verbal acknowledgment is received and stored in a persistent data store.

Abstract: Disclosed is a long wearing cosmetic product with elegant glide and feel with cooling sensation and impactful color intensity with high coverage. The disclosed combination of a silicone resin, an ethylenic polymer including a monomer having a bicyclic group, and a taurate copolymer provides a flexible/soft film on eye lids which is not brittle and wears longer for hours.

Abstract: The present disclosure relates to anhydrous cosmetic composition comprising hydrophobic silica particles, PMMA particles, silicone oil, hydrocarbon oil, silicone elastomer and silicone emulsifier.

Abstract: Compositions including an aqueous phase emulsified within an external fatty phase comprising at least one silicone are provided. The compositions include iron oxide having a silane-treated surface, zinc-oxide having a silane-treated surface, a titanium dioxide-silica composite particulate, and hollow spheres of acrylic polymer.

Abstract: An apparatus for automatically cleaning and sanitizing soles of bare feet and footwear, said apparatus including a plurality of nozzle heads that spray cleaning and sanitizing fluid through a platform onto feet and footwear placed on the top surface of the platform. A sensor plate initiates the cleaning and sanitization process when activated, and a visual display and audible tones alert a user as to the current step being executed by the automated cleaning apparatus. A refillable or replaceable canister or aerosol can of cleaning and sanitizing fluid is housed within the automated cleaning apparatus for supplying said liquid via a tubing system to the plurality of nozzle heads that are directed onto the platform.

Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.

Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.

Abstract: An apparatus for automatically cleaning and sanitizing soles of bare feet and footwear, said apparatus including a plurality of nozzle heads that spray cleaning and sanitizing fluid through a platform onto feet and footwear placed on the top surface of the platform. A sensor plate initiates the cleaning and sanitization process when activated, and a visual display and audible tones alert a user as to the current step being executed by the automated cleaning apparatus. A refillable or replaceable canister or aerosol can of cleaning and sanitizing fluid is housed within the automated cleaning apparatus for supplying said liquid via a tubing system to the plurality of nozzle heads that are directed onto the platform.